High IREB2 correlated with improved lung cancer prognosis (nonsignificant in LUSC), high PSMA4 expression correlates with poor prognosis in lung cancer overall but demonstrates a favorable association in LUAD patients​ (Figure 4C). This evidence concerns the gene IREB2 and lung carcinoma.